Deutsche Bank’s CAMP4 Therapeutics CAMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$112K Sell
27,670
-3,919
-12% -$16.1K ﹤0.01% 3328
2026
Q2
$138K Buy
+31,589
New +$136K ﹤0.01% 3402
2025
Q2
– Sell
-4,643
Closed -$18.6K – 3624
2025
Q1
$18.6K Buy
+4,643
New +$22.5K ﹤0.01% 3479

Other funds holding CAMP

Deutsche Bank's CAMP Position: Q3 2026 in Review

Deutsche Bank reduced its CAMP4 Therapeutics (CAMP) stake by 12% in Q3 2026, selling an estimated $16.1K and leaving 27,670 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #3328.

Deutsche Bank first reported a position in CAMP in Q1 2025 and has held it in 3 quarters since. The position peaked at $138K in Q2 2026. 67 funds tracked by Wall St. Rank hold CAMP as of Q3 2026.

  • Deutsche Bank held 27,670 shares of CAMP4 Therapeutics worth $112K as of Q3 2026.
  • Deutsche Bank sold 3,919 CAMP4 Therapeutics shares in Q3 2026, an estimated $16.1K.
  • CAMP4 Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #3328 holding.
  • Deutsche Bank first reported a position in CAMP4 Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • Deutsche Bank's CAMP4 Therapeutics position peaked at $138K in Q2 2026.
  • 67 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.